VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Telomir Pharmaceuticals, Inc. Common Stock (TELO) Total Return Calculator with Dividends Reinvested

Telomir Pharmaceuticals, Inc. Common Stock

Popular:

The total return for Telomir Pharmaceuticals, Inc. Common Stock (TELO) stock is -46.61% over the past 12 months. So far it's up 0.00% this year. The 5-year total return is -80.86%, meaning $10,000 invested in TELO stock 5 years ago would be worth $1,914 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in TELO 1 year ago, it would be worth $5,382 today — you'd have lost $4,618.

With Dividends Reinvested$5,382-46.18%

Price Only (No DRIP)$5,382-46.18%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in TELO

1Y$5,339-$4,661 (-46.6%)-46.6% CAGR

3Y$1,914-$8,086 (-80.9%)-42.4% CAGR

5Y$1,914-$8,086 (-80.9%)-28.2% CAGR

10Y$1,914-$8,086 (-80.9%)-15.2% CAGR

15Y$1,914-$8,086 (-80.9%)-10.4% CAGR

20Y$1,914-$8,086 (-80.9%)-7.9% CAGR

30Y$1,914-$8,086 (-80.9%)-5.4% CAGR

Telomir Pharmaceuticals, Inc. Common Stock did not pay dividends during this period. Total return = price return.

Loading TELO total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+0.00%	—	+0.00%	—	$10,000
1Y	-46.61%	-46.61%	-46.61%	—	$5,339
3Y	-80.86%	-42.37%	-80.86%	—	$1,914
5Y	-80.86%	-28.15%	-80.86%	—	$1,914
10Y	-80.86%	-15.24%	-80.86%	—	$1,914
15Y	-80.86%	-10.44%	-80.86%	—	$1,914
20Y	-80.86%	-7.93%	-80.86%	—	$1,914
30Y	-80.86%	-5.36%	-80.86%	—	$1,914

Risk & Highlights

Best Year-41.14%2024

Worst Year-67.32%2025

Max Drawdown-60.73%2025-05-13 → 2026-02-12

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-5.22%	-5.22%	—	+0.41%	-5.6pp
2025	-67.32%	-67.32%	—	+16.64%	-84.0pp
2024	-41.14%	-41.14%	—	+24.00%	-65.1pp

TELO underperformed the S&P 500 by 77.94pp over the past year (-46.61% vs +31.32%).

Loading summary...

TELO Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
TELOTelomir Pharmaceuticals, Inc. Common Stock	$46M	+3.1%	+0.0%	-46.6%	—	-80.9%	-80.9%	-80.9%
TARAProtara Therapeutics, Inc.	$303M	+11.6%	+5.2%	+68.0%	—	+83.2%	-42.1%	-98.2%
ADTXAditxt, Inc.	$69,911	-77.4%	-98.1%	-100.0%	—	-100.0%	-100.0%	-100.0%
AEYEAudioEye, Inc.	$95M	+22.6%	-23.0%	-35.7%	—	+14.2%	-63.7%	+80.2%
INVAInnoviva, Inc.	$1.9B	-2.2%	+13.3%	+20.4%	—	+92.8%	+95.5%	+90.5%
LCTXLineage Cell Therapeutics, Inc.	$348M	-7.1%	-12.8%	+228.7%	—	-4.0%	-49.5%	-46.6%
NKTRNektar Therapeutics	$1.7B	+13.9%	+96.0%	+783.6%	—	+636.7%	-69.4%	-57.6%
AGIOAgios Pharmaceuticals, Inc.	$1.6B	-22.5%	-0.7%	-4.7%	—	+6.2%	-51.0%	-38.1%
ILMNIllumina, Inc.	$21.7B	+11.6%	+6.1%	+91.3%	—	-25.0%	-61.1%	+4.3%
TMOThermo Fisher Scientific Inc.	$175.8B	-3.1%	-20.1%	+16.6%	+0.4pp	-11.9%	+2.1%	+229.1%
CRLCharles River Laboratories International, Inc.	$9.0B	+8.0%	-10.2%	+57.5%	—	-4.3%	-46.0%	+124.7%

Compare:TELO vs TARA TELO vs ADTX TELO vs AEYE TELO vs TARA vs ADTX

About TELO Dividend Returns

Telomir Pharmaceuticals, Inc. Common Stock (TELO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of TELO over the past year?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) delivered a return of -46.61% over the past year. Since TELO does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in TELO be worth today?

A $10,000 investment in Telomir Pharmaceuticals, Inc. Common Stock one year ago would be worth $5,339 today, representing a loss of $4,661.

Q3Does TELO pay dividends?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For TELO, the total return equals the price-only return.

Q4Did TELO beat the S&P 500?

No, Telomir Pharmaceuticals, Inc. Common Stock (TELO) underperformed the S&P 500 by 77.94 percentage points over the past year. TELO delivered a total return of -46.61%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed TELO by 77.94pp during this period.

Q5What is TELO's worst drawdown?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) experienced a maximum drawdown of -60.73% over the past year, declining from its peak on 2025-05-13 to its trough on 2026-02-12. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is TELO's long-term total return over 10, 20, or 30 years?

Here are Telomir Pharmaceuticals, Inc. Common Stock (TELO)'s long-term returns with dividends reinvested. Over 10 years, the total return is -80.9% (-15.2% CAGR) — $10,000 would have grown to $1,914. Over 20 years: -80.9% total return (-7.9% CAGR) — $10,000 → $1,914. Over 30 years: -80.9% total return (-5.4% CAGR) — $10,000 → $1,914. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was TELO's best and worst year?

Telomir Pharmaceuticals, Inc. Common Stock's best calendar year was 2024 with a total return of -41.1%. Its worst year was 2025 with a total return of -67.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 26.2 percentage points.